Will Kenvue report FY2025 organic sales decline worse than -4%?

Management guided 'down low single digits' for FY2025, implying -1% to -4%. Q1 organic was -1.2%, Q2 segments showed Self Care -5.9%, SH&B -3.7%, Essential Health -2.4% — blended Q2 organic around -4%. However, global consumption was positive across all segments, suggesting inventory/channel effects may normalize in H2. The question asks about worse than -4%, which is the low end of 'low single digits.' With H1 tracking around -2.5% blended, H2 would need to be materially worse than -5% to push the full year below -4%. This is possible but not the base case given consumption trends.

The -4% threshold is aggressive. Management's revised guidance of 'down low single digits' was issued in Q2 2025 — they had visibility into Q3 trends and chose a range that accommodates the current trajectory. Management teams generally set revised guidance with enough cushion to avoid a further miss. The $150M tariff headwind was already factored into the guidance revision. Unless there was a dramatic H2 deterioration beyond what management anticipated (unlikely given positive consumption), FY2025 organic should land in the -2% to -4% range, not worse than -4%.

Q2 2025 segment data is concerning — -5.9% Self Care is quite weak. If tariff headwinds ($150M gross, ~1% of revenue) hit harder in H2 and pricing actions further compressed volume, a full-year worse than -4% is within the distribution. The management transition (CEO + CFO replaced) could cause execution wobbles during H2. Low confidence because we lack H2 2025 data — the analysis fundamentals are ~210 days stale. But the base case remains that management's guidance revision captured the trajectory.

Management guided 'down low single digits' which in CPG parlance typically means -1% to -3%. They have already revised once and have visibility. Positive consumption across all segments is a strong signal that brand health is intact. The -4% threshold is at the extreme low end of the guidance range. For the full year to be worse than -4%, Q3-Q4 would need to deteriorate significantly from H1, which contradicts the positive consumption trend. 28% probability.

The data shows a company in organic decline but with positive underlying consumption. The gap between consumption and organic sales reflects inventory management, trade promotion timing, and channel mix issues — these tend to normalize over a full year. The -4% threshold is specifically challenging: Q2 organic was approximately -4% blended, but Q1 was only -1.2%. Even if Q3-Q4 tracked Q2 levels (~-4%), the full year would be around -3% given the better Q1. Need Q3-Q4 to be worse than -5% to break -4% full year.

The math works against worse than -4%. Q1 at -1.2% is an anchor that pulls the full year toward a better number. Even with Q2 blended at ~-4% and Q3-Q4 at -4%, the full year would be approximately -3.3%. To reach worse than -4% FY, you'd need a significant acceleration of decline in H2 beyond what the data supports. Tariff impact is the main risk that could push Q3-Q4 worse, but it's ~1% of revenue gross. 33% probability.

Management guided low single digits with Q3 visibility. Positive consumption across segments limits downside. Q1 at -1.2% provides favorable averaging. Below 30% probability for worse than -4% full year.

The -4% threshold is demanding. Q2 was the trough quarter with Self Care -5.9% dragging the blended number down. H2 should stabilize or improve given consumption trends and management actions. Full-year most likely lands -2% to -3.5%. 30% probability of worse than -4%.

Positive global consumption is the strongest signal against accelerating organic decline. Management's guidance revision already incorporated the deterioration. Tariff headwinds are meaningful but not enough to push full-year below -4% on their own. 28% probability.